Strategic Outsourcing for Pharmaceuticals and Biologics - Webinar By ComplianceOnline (Biotech)
|Event Date/Time: Jul 21, 2011||End Date/Time: Jul 21, 2011|
The continuing trend toward outsourcing non-core activities in Pharmaceuticals and Biologics has created a pressing need for companies to understand the strategic nature of outsourcing and the proper management of contractual relationships.
The third party nature of outsourcing calls for competency sets that are very different from the traditional in-house ways of operating. Selection of appropriate partners that will integrate well into your business is essential, as is the need to incorporate strong contractual agreements that underpin the needs of the working relationship.
This seminar aims to arm participants with the skills of strategic procurement, helping them understand how to segment their contractor and supplier base so that maximum impact is gained. Then, to present practical ways in which the operational elements can be built and managed to ensure the needs of their customers are fully represented through effective shared working practices â€“ delivering quality, cost and lead-time benefits for the organizations they represent.
Understand and deliver on the value proposition for both parties in the relationship, achieving greater value from the procurement spend.
Discover how to build stronger third party relationships and cross-business alliances.
Focus on the actions that can transform performance in terms of quality/compliance, cost and lead time.
Find ways to achieve greater compliance with regulatory expectations when dependant on contractor services.
Reduce the risk of delays and failure in achieving key milestones such as study initiation, drug delivered to site and study close-out.
Increase confidence in driving continuous improvement through the organization.
Areas Covered in the Seminar :
The outsourcing model â€“ when, and when not, to outsource.
Segmenting the procurement portfolio using models such as the Kraljic Matrix.
Strategic sourcing and source planning.
Adverse selection and post-contractual moral hazard .
The procurement cycle and stakeholder engagement.
Investigator/Development/Supply/Quality/Technical/Distributor/Service Level Agreements.